openPR Logo
Press release

Regenerative Medicine Market worth USD 17.9 billion by 2025 - Leading Companies are 3M Group, Novartis AG, Integra Lifesciences Holdings Corporation, Stryker Corporation and Smith & Nephew

11-27-2020 12:08 PM CET | Health & Medicine

Press release from: MarketsandMarkets

Regenerative Medicine Market worth USD 17.9 billion by 2025 -

According to the new market research report "Regenerative Medicine Market by Product (Cell Therapies (Autologous, Allogenic), Stemcell Therapy, Tissue-engineering, Gene Therapy), Application (Wound Care, Musculoskeletal, Oncology, Dental, Ocular), Geography - Global Forecast to 2025", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia Pacific, and Rest of the World.

Regenerative Medicine Market is projected to reach USD 17.9 billion by 2025 from USD 8.5 billion in 2020, at a CAGR of 15.9%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65442579#utm_source=Openpr&utm_medium=paidpr

Growth in this market is largely driven by the rising prevalence of chronic diseases, genetic disorders, and cancer; rising investments in regenerative medicine research; and the growing pipeline of regenerative medicine products.

The tissue-engineered products segment accounted for the largest share of the Regenerative Medicine Market, by product segment, in 2019

Based on products, the market is segmented into tissue-engineered products, cell therapies, gene therapies, and progenitor and stem cell therapies. The tissue-engineered products segment accounted for the largest share in the market in 2019. The increasing adoption of tissue-engineered products for the treatment of chronic wounds and musculoskeletal disorders and the rising funding for the R&D of regenerative medicine products and therapies are the major factors driving the growth of this segment.

Browse and in-depth TOC on "Regenerative Medicine Market"
131 - Tables
38 - Figures
165 - Pages
Get 10% Customization Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=65442579#utm_source=Openpr&utm_medium=paidpr

Oncology segment to register the highest growth rate during the forecast period

Based on applications, the Regenerative Medicine Market is segmented into musculoskeletal disorders, wound care, oncology, ocular disorders, dental, and other applications. In 2019, the oncology segment accounted for the highest growth rate. This can be attributed to the rising prevalence of orthopedic diseases, growing geriatric population, increasing number of stem cell research projects, growing number of clinical researches/trials, and the rich pipeline of stem cell products for the treatment of musculoskeletal disorders.

North America is the largest regional market for Regenerative Medicine Market

The market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2019, North America accounted for the largest share in the market. The growth in the North American market can be attributed to rising stem cell banking, tissue engineering, and drug discovery in the region; expansion of the healthcare sector; and the high adoption of stem cell therapy and cell immunotherapies for the treatment of cancer and chronic diseases.

Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=65442579#utm_source=Openpr&utm_medium=paidpr

Key Players

The major players operating in this Regenerative Medicine Market are 3M (US), Allergan plc (Ireland), Amgen, Inc. (US), Aspect Biosystems (Canada), bluebird bio (US), Kite Pharma (US), Integra LifeSciences Holdings Corporation (US), MEDIPOST Co., Ltd. (South Korea), Medtronic plc (Ireland), Anterogen Co., Ltd. (South Korea), MiMedx Group (US), Misonix (US), Novartis AG (Switzerland), Organogenesis Inc. (US), Orthocell Limited (Australia), Corestem, Inc. (South Korea), Spark Therapeutics (US), APAC Biotech (India), Shenzhen Sibiono GeneTech Co., Ltd. (China), Smith & Nephew plc (UK), Stryker Corporation (US), Takeda Pharmaceutical Company Limited (Japan), Tego Science (South Korea), Vericel Corporation (US), and Zimmer Biomet (US).

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth emerging opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's™ flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Regenerative Medicine Market worth USD 17.9 billion by 2025 - Leading Companies are 3M Group, Novartis AG, Integra Lifesciences Holdings Corporation, Stryker Corporation and Smith & Nephew here

News-ID: 2197647 • Views: 898

More Releases from MarketsandMarkets

Silicone Market worth $23.3 billion by 2025 | Key Players include Dow, Wacker Ch …
According to recent market research "Silicone Market by Type (Elastomers, Fluids, Resins, Gels), End-use Industry (Industrial Process, Building & Construction, Personal Care & Consumer Products, Transportation, Electronics, Medical & Healthcare, Energy), Region - Global Forecasts to 2025", size is expected to grow from USD 14.0 billion in 2020 to USD 23.3 billion by 2025, at a CAGR of 10.7% during the forecast period. The major factors driving the silicone industry
Portable Projector Market worth $1.9 billion by 2025
The report "Portable Projector Market with COVID-19 Impact Analysis, Technology (DLP,LCD, LCOS), Dimension (2D,3D), Lumen(Below 500, 500 to 3,000, Above 3,000), Resolution(VGA,XGA, HD & FHD), Projection, Application, and Region - Global Forecast to 2025", is projected to grow from USD 1.5 billion in 2020 to USD 1.9 billion by 2025; it is expected to grow at a CAGR of 4.3% from 2020 to 2025. The key factors fueling the growth
Marine Battery Market worth $812 million by 2025
The report "Marine Battery Market by Battery Type (Lithium, Fuel Cell, Lead-acid), Propulsion Type (Fully Electric, Hybrid, Conventional), Application, Sales Channel, Ship Range, Nominal Capacity, Battery Design, Battery Function, and Region - Global Forecast to 2025", is estimated to be USD 250 million in 2020 and is projected to reach USD 812 million by 2025, at a CAGR 48.1% from 2020 to 2025. Implementation of sulfur 2020 rule and rise
Crystal Oscillator Market worth $3.1 billion by 2025
The report "Crystal Oscillator Market with COVID-19 Impact Analysis by General Circuity (SPXO, TCXO, VCXO), Crystal Cut (AT Cut, BT Cut, SC Cut), Mounting Scheme (Surface Mount, Through-Hole) Application (Consumer Electronics), Geography - Global Forecast to 2025",, size is projected to reach USD 3.1 billion by 2025 from an estimated USD 2.8 billion in 2020, at a CAGR of 2.1% from 2020 to 2025. Rising development of 5G networks is

All 5 Releases


More Releases for Regenerative

Global Regenerative Medicines Market Research Report Trend
Qyresearchreports include new market research report Global Regenerative Medicines Market Research Report 2021 to its huge collection of research reports. Serving as an invaluable source of guidance for individuals as well as companies, the latest report added to QYResearchReports.com studies the global Regenerative Medicines market and provides a new perspective on the workings and components of the market on a global as well as regional level. The research study analyzes the
Regenerative Medicine Landscape
Boston, MA ReportsWorldwide has announced the addition of a new report title Regenerative Medicine Landscape to its growing collection of premium market research reports. The competitive landscape for regenerative medicine continues to evolve. As private sector investment in active players continues, efforts by governments in the US and EU are helping to advance the field, including the recent passage of the 21st Century Cures Act in the US, providing a special status
Regenerative Medicine Market - Global Industry Analysis 2024
Regenerative medicines are medical products or active pharmaceutical ingredients that have the ability to cure or replace organs and tissues organs damaged by various factors such as aging, diseases, trauma, and can also be used to provide stability in congenital disorders. According to findings of various studies, regenerative medicines can also be useful in treating both chronic and acute disorders in terms various context of abnormalities such as cardiovascular diseases,
Regenerative Medicines Sales Report 2017
"Global Regenerative Medicines Sales Market Report 2017" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. . . Description- '
Regenerative Medicine Market - Global Industry Analysis 2024
Regenerative medicines are medical products or active pharmaceutical ingredients that have the ability to cure or replace organs and tissues organs damaged by various factors such as aging, diseases, trauma, and can also be used to provide stability in congenital disorders. According to findings of various studies, regenerative medicines can also be useful in treating both chronic and acute disorders in terms various context of abnormalities such as cardiovascular diseases,
Regenerative Medicine Market - Global Industry Analysis 2024
Regenerative medicines are medical products or active pharmaceutical ingredients that have the ability to cure or replace organs and tissues organs damaged by various factors such as aging, diseases, trauma, and can also be used to provide stability in congenital disorders. According to findings of various studies, regenerative medicines can also be useful in treating both chronic and acute disorders in terms various context of abnormalities such as cardiovascular diseases,